Abstract
end, fluorescence imaging has largely facilitated the development of novel diagnostics and 23 treatments with improved selectivity for fungi over host cells and other pathogens [17] [18] [19] [20] [21] .
25
Whereas fluorescent probes can be rationally designed to target specific targets or even cell 26 types [22, 23] , they are often conjugated to other chemical structures that confer them with 27 molecular recognition properties for enhanced target specificity. These can include small 
6
Peptides have been increasingly recognised as promising scaffolds to generate agents for 7 molecular imaging, partially due to their ability to form highly specific interactions with their 8 respective targets [35] [36] [37] . This section summarises recent progress on the preparation and showed that both LL-37 and CATH-2 exhibited rapid strong membrane staining, however their 7 internalisation was energy-independent, suggesting direct membrane permeabilisation as the 8 main mechanism of action [53] . Unlike histatin-5 and PAF26, both LL-37 and CATH-2 showed 9 lack of fungal specificity and rather general antimicrobial properties, with almost identical 
27
The studies mentioned above demonstrate the utility of fluorescent peptides for in situ analysis 
22
The detection and characterisation of other fungi by PNA-FISH has also been described. it has been used to detect cancer cells, which present metabolic demands that are different
21
from most normal cells [101] . Recently FDG has been also used in PET/CT imaging for 
16
PET/CT-imaging biodistribution and pharmacokinetics studies on non-human primates.
17
Finally,
68
Ga-NOTA-ubiquicidin was tested in a small cohort of humans and proven as nontoxic 
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